Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$2.88M Buy
188,541
+31,519
+20% +$350K 0.01% 1064
2020
Q3
$1.25M Buy
157,022
+17,737
+13% +$171K ﹤0.01% 1335
2020
Q2
$1.36M Buy
139,285
+7,412
+6% +$67.9K 0.01% 1275
2020
Q1
$758K Buy
131,873
+85,225
+183% +$1.77M ﹤0.01% 1420
2019
Q4
$1.58M Sell
46,648
-6,443
-12% -$175K 0.01% 1199
2019
Q3
$1.44M Sell
53,091
-3,277
-6% -$95.7K 0.01% 1213
2019
Q2
$1.89M Buy
56,368
+6,483
+13% +$235K 0.01% 1082
2019
Q1
$2.05M Sell
49,885
-4,208
-8% -$156K 0.01% 1031
2018
Q4
$1.47M Buy
54,093
+1,854
+4% +$68.2K 0.01% 1115
2018
Q3
$2.28M Buy
52,239
+7,864
+18% +$330K 0.01% 1005
2018
Q2
$1.85M Buy
+44,375
New +$1.82M 0.01% 1065

Other funds holding CHX

Aperio Group's CHX Position: Q4 2020 in Review

Aperio Group increased its ChampionX (CHX) stake by 20% in Q4 2020, buying an estimated $350K and bringing the position to 188,541 shares worth $2.88M. The position accounts for 0.01% of the portfolio, ranked #1064.

Aperio Group first reported a position in CHX in Q2 2018 and has held it in 11 quarters since. 302 funds tracked by Wall St. Rank hold CHX as of Q4 2020.

  • Aperio Group held 188,541 shares of ChampionX worth $2.88M as of Q4 2020.
  • Aperio Group bought 31,519 ChampionX shares in Q4 2020, an estimated $350K.
  • ChampionX made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1064 holding.
  • Aperio Group first reported a position in ChampionX in Q2 2018 and has held it in 11 quarters since.
  • 302 funds tracked by Wall St. Rank held ChampionX as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.